EMA Denies Approval of Yaz for Moderate Acne

On April 19, 2012, the European Medicines Agency (EMA) denied approval for Yaz birth control pills to be marketed as a treatment for moderate acne, because they were concerned that young women would choose to treat their acne with Yaz when there were other, safer acne treatments. In a statement, the Agency’s Committee for…

Read More

Naturalyte Lawsuit

Naturalyte, along with Granuflo Dry Acid Concentrate, is used in the treatment of acute and chronic renal failure during hemodialysis. It was specifically formulated to be used with a three-stream hemodialysis machine, which assists in the removal of toxins from the blood when the kidney is unable to do so on its own. Of…

Read More

Lack of Reversal Agent Compounds Growing Concern For Blood-Thinning Medication

The recent approval of Pradaxa (generic: dabigatran) by the U.S. Food and Drug Administration (FDA) has simultaneously become the subject of increasing criticism and concern. Not only has the anti-blood clotting medication been associated with the development of internal bleeding, but it has seemingly rendered medical intervention irrelevant in certain populations. Subsequently, Pradaxa’s lack…

Read More

FDA Sends Warning Letters to DMAA Manufacturers

April 28, 2012 – On Friday, the U.S. Food & Drug Administration (FDA) issued warning letters to 10 manufacturers and distributors of dietary supplements containing dimethylamylamine (DMAA) for failing to submit evidence of the safety of their products. Popular with fitness buffs seeking an edge or weight loss, DMAA has recently been linked to…

Read More

Industry Professionals Discuss Sexual Side Effects of Propecia at World Meeting on Sexual Medicine

Propecia (generic: finasteride) has become the subject of intense scrutiny following recent reports that associate the hair restoration medication with catastrophic complications. Adverse reports, following Propecia treatment, suggest an increased propensity for the development of serious sexual side effects that persist beyond the discontinuation of the drug. The volatile situation surrounding Propecia treatment has…

Read More

Loryna® Pulmonary Embolism Lawyer & Lawsuit

Please note, The Senators (Ret.) Firm, LLP is no longer accepting Loryna claims. If you feel that you may have a potential case, we urge you to locate another law firm adequately suited to handle your claim. The development of pulmonary embolism is directly correlated to the presence of severe blood clots. Blood clots…

Read More

Revatio Lawsuit

Revatio (generic: sildenafil) is a prescription medication that is indicated to assist in the treatment of pulmonary arterial hypertension (PAH). Of significant concern, however, are recent studies cautioning the use of Revatio by certain populations. According to a long-term clinical pediatric trial, children under the age of 18 should not take Revatio due to…

Read More

DMAA Supplement Manufacturers Look Toward ‘All-Natural’ Alternatives

In response to a firm warning letter sent to them by the U.S. Food & Drug Administration (FDA), a number of companies whose dietary supplements include the controversial ingredient DMAA are attempting to make a future without it. According to the FDA, there is no credible scientific evidence that shows DMAA deserves to be…

Read More